Company
Leuko
The first noninvasive device for white blood cell measurement.
Also known as LEUKO LABS, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B2C
- Customers
- For Patients & Caregivers; For Clinicians
- Legal name
- LEUKO LABS, INC.
- leuko.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Improving quality of life and outcomes for cancer patients and others at risk of severe neutropenia, through the first noninvasive white blood cell monitor.
Funding snapshot
- Total raised
- $11.3MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Grant, $4.5M2024-07
Funding rounds
- Grant
- $4.5M2024-07, Company stated
- Series A
- $5M2022-09, Company stated
- Seed
- $1.8M2019-07, Company stated
- Round, 2019
- $1.2M2019-02-01, SEC form D sold, 14 investors
Products
- Hardware
- PointCheck
- Hardware
- PointCheck™
Loading relationship preview